Cargando…
Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients
A key aspect to vaccine efficacy is formulation stability. Biochemical evaluations provide information on optimal compositions or thermal stability but are routinely validated by ex vivo analysis and not efficacy in animal models. Here we assessed formulations identified to improve or reduce stabili...
Autores principales: | Stone, Addison E., Rambaran, Saraswatie, Trinh, Ivy V., Estrada, Marcus, Jarand, Curtis W., Williams, Blake S., Murrell, Amelie E., Huerter, Chelsea M., Bai, William, Palani, Surya, Nakanishi, Yukihiro, Laird, Renee M., Poly, Frederic M., Reed, Wayne F., White, Jessica A., Norton, Elizabeth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308557/ https://www.ncbi.nlm.nih.gov/pubmed/36732163 http://dx.doi.org/10.1016/j.vaccine.2023.01.033 |
Ejemplares similares
-
The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
por: Clements, John D., et al.
Publicado: (2018) -
Identifying a stable bulk dmLT adjuvant formulation at a clinically relevant concentration
por: Estrada, Marcus R., et al.
Publicado: (2023) -
Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge
por: Stone, Addison E., et al.
Publicado: (2021) -
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge
por: Coria, Lorena M., et al.
Publicado: (2020) -
dmLT Adjuvant Enhances Cytokine Responses to T Cell Stimuli, Whole Cell Vaccine Antigens and Lipopolysaccharide in Both Adults and Infants
por: Akhtar, Marjahan, et al.
Publicado: (2021)